A global leader in biopharmaceutical and laboratory equipment, the company specializes in providing solutions for bioprocessing and laboratory workflows. Its products are critical for drug development, vaccine production, and research, making it a key player in the life sciences sector. Investors monitor its performance due to its exposure to high-growth biotech and pharmaceutical markets.
1 member of Congress has disclosed 1 trade in Sartorius AG (SOAGY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |